Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 17764887)

Published in Eur J Surg Oncol on August 30, 2007

Authors

G Morris-Stiff1, Y-M Tan, J N Vauthey

Author Affiliations

1: Department of Hepatobiliary Surgery, St James Hospital, Leeds, UK. garethmorrisstiff@hotmail.com

Articles citing this

Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol (2012) 1.15

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) (2012) 1.07

Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol (2011) 1.04

A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) (2012) 1.01

Liver injury induced by anticancer chemotherapy and radiation therapy. Int J Hepatol (2013) 0.93

Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg (2010) 0.90

A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery. HPB (Oxford) (2012) 0.89

A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer (2010) 0.87

Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury. Korean J Pathol (2012) 0.86

National trends in discharge disposition after hepatic resection for malignancy. HPB (Oxford) (2011) 0.85

Pancreatic cancer and FOLFIRINOX: a new era and new questions. Cancer Med (2015) 0.84

Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? World J Gastroenterol (2015) 0.83

Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review. Int J Clin Oncol (2011) 0.79

Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer. Protein Cell (2016) 0.79

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy. Clin Mol Hepatol (2014) 0.78

Advances in therapeutics for liver metastasis from colorectal cancer. World J Gastrointest Oncol (2010) 0.77

Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy. Langenbecks Arch Surg (2011) 0.77

Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity. HPB (Oxford) (2012) 0.76

Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates. Korean J Radiol (2017) 0.75

Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) (2009) 0.75

Capecitabine-related liver lesions: sinusoidal dilatation mimicking liver metastasis. Clin Case Rep (2016) 0.75

Hepatic colorectal metastases involving infra-hepatic inferior vena cava in high risk patients for extended resection: an alternative method for achieving radical resection in patient with borderline liver remnant. Indian J Surg (2012) 0.75

Acute renal injury after partial hepatectomy. World J Hepatol (2016) 0.75

Effects of oxaliplatin-based chemotherapy on liver function-an analysis of impact and functional recovery using the LiMAx test. Langenbecks Arch Surg (2015) 0.75

Articles by these authors

Portal vein embolization: rationale, technique and future prospects. Br J Surg (2001) 2.41

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol (2001) 2.24

Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol (2001) 1.77

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys (2002) 1.69

Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery (2001) 1.60

Laparoscopy in the staging of pancreatic cancer. Br J Surg (2001) 1.59

Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys (2002) 1.44

Squamous cell carcinoma of the anal margin. Oncology (Williston Park) (1996) 1.40

Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol (2000) 1.31

Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg (2001) 1.29

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res (2001) 1.06

Adenocarcinoma of the upper esophagus arising in cervical ectopic gastric mucosa: rare evidence of malignant potential of so-called "inlet patch". Dig Dis Sci (1998) 1.04

Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol (2001) 1.03

A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg (2001) 1.01

Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors. Cancer (1993) 0.96

Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer (2001) 0.94

T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys (2001) 0.94

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. Semin Oncol (2001) 0.93

Importance of field cancerisation in clinical oncology. Lancet Oncol (2000) 0.93

Hepatic tumor necrosis factor-alpha production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg (1996) 0.92

Monolobar Caroli's Disease and cholangiocarcinoma. HPB Surg (1999) 0.90

Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol (1997) 0.88

Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res (1998) 0.88

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med (1996) 0.88

Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal. Int J Radiat Oncol Biol Phys (2001) 0.87

Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology. Eur J Surg Oncol (2009) 0.87

Prospective evaluation of the giant prosthetic reinforcement of the visceral sac for recurrent and complex bilateral inguinal hernias. Am J Surg (1999) 0.85

Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. J Gastrointest Surg (2002) 0.84

Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. Hepatogastroenterology (1998) 0.84

Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol (2007) 0.84

Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation. Transplant Proc (2012) 0.82

Carcinoma of the extrahepatic biliary tract: surgery and radiotherapy for curative and palliative intent. Radiat Oncol Investig (1998) 0.81

Evaluation of adaptive changes by non-invasive imaging in hepatic vein outflow obstruction. HPB Surg (1995) 0.81

A simplified staging system for hepatocellular carcinomas. Gastroenterology (1995) 0.80

On the uniform use of the AJCC/UICC staging system for hepatocellular carcinoma. Surgery (2000) 0.80

Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer (1996) 0.79

Conservative treatment of rectal adenocarcinoma with endocavitary irradiation or wide local excision and postoperative irradiation. J Clin Oncol (1997) 0.79

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations. Tissue Antigens (2009) 0.77

Biliary tract cancer. Curr Opin Gastroenterol (2000) 0.77

Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. Leukemia (2009) 0.77

Resolution of nonbacterial endocarditis after surgical resection of a malignant liver tumor. Circulation (2000) 0.77

Squamous cell carcinoma of the anal margin treated with radiotherapy. Surg Oncol (1996) 0.77

Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review. J Int Med Res (2012) 0.76

Selective management of patients with neutropenic enterocolitis using peritoneal lavage. J Surg Oncol (1990) 0.76

Treatment of unresectable hepatocellular carcinoma. N Engl J Med (1995) 0.75

Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (Br J Surg 2002; 89: 57-62). Br J Surg (2002) 0.75

Postoperative liver failure. J Am Coll Surg (1999) 0.75

Colorectal cancer: surgical management of recurrent and metastatic disease. J Natl Med Assoc (1988) 0.75

Hepatic colorectal metastases and extrahepatic disease. J Surg Oncol (2001) 0.75

[Botulism: apropos of a local epidemic]. Schweiz Med Wochenschr (1984) 0.75

Biliary tract cancer. Curr Opin Gastroenterol (1999) 0.75

Pathology of the arterial hepato-cystic network. Helv Chir Acta (1985) 0.75

Experimental evaluation of an endoscopic balloon for manometry of esophageal varices. Gastroenterology (1991) 0.75

Biliary tract cancer. Curr Opin Gastroenterol (2001) 0.75

Recurrent peptic ulceration after highly selective vagotomy: long-term outcome. Br J Surg (1991) 0.75

Adult Hirschsprung's disease presenting as sigmoid volvulus: a case report and review of literature. Tech Coloproctol (2006) 0.75

Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation. Transplant Proc (2012) 0.75

Is limb-sparing surgery applicable to neurogenic sarcomas of the extremities? Arch Surg (1989) 0.75

The approach to large left ventricular aneurysms. A report of three difficult cases. J Cardiovasc Surg (Torino) (1989) 0.75

A rare cause of severe bleeding from the anterior duodenal wall: the cystic artery. J Clin Gastroenterol (1991) 0.75